TrialCancer chemotherapy and pharmacology2010

Phase I/II study on docetaxel, gemcitabine and prednisone in castrate refractory metastatic prostate cancer.

Trine Zeeberg Buch-Hansen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.